Murine models of UTI infection caused by antibiotic-resistant bacteria
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Pharmacology Discovery Services Taiwan, LTD. UEI MXP1NVQ8C1J8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,260
Award facts
- Contract value 50% obligated
-
- $599,260.00 Current, with exercised options
- $1,193,205.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $141,700 | |
| Funding Only Action | -$70,138 | |
| Exercise an Option | $70,138 | |
| Exercise an Option | $141,700 | |
| Original award | $315,860 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 19, 2023, with a ceiling value of $1,193,205 to exercise Option 5B under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract for murine models of antibiotic-resistant urinary tract infection. Ultimate completion date is February 27, 2025.
Place of performance is Taiwan. The order is priced on a firm fixed price basis and carries no set-aside designation. Pharmacology Discovery Services Taiwan specializes in preclinical infectious disease research, designing and producing mouse models that simulate bacterial infections for therapeutic evaluation and medical countermeasure testing.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 19, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $599,260 on 75N93023F00001. Its potential value, with all options, is $1,193,205.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under HHSN272201700020I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award